default author photo

Wei Qi Yao

Huazhong University of Science and Technology - Department of Hematology

1277 Jiefang Avenue

Wuhan, 430022

China

SCHOLARLY PAPERS

3

DOWNLOADS

259

TOTAL CITATIONS

9

Scholarly Papers (3)

1.

Treatment with Human Umbilical Cord-Derived Mesenchymal Stem Cells for Severe COVID-19 Patients with Lung Damage: A Randomised, Double-Blind, Placebo‑Controlled Phase 2 Trial

Number of pages: 36 Posted: 14 Oct 2020
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Second Military Medical University - Department of Respiratory, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Fifth Medical Center of Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Wuhan Huoshenshan Hospital, Huazhong University of Science and Technology - Department of Hematology, Wuhan Huoshenshan Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Endocrinology and Metabolism, Huazhong University of Science and Technology - Department of Radiology, Wuhan Huoshenshan Hospital, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - General Hospital of Beijing Military Region, Chinese PLA General Hospital - Department of Infectious Diseases, Peking University - Clinical Research Institute, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 133 (558,171)
Citation 7

Abstract:

Loading...

COVID-19, Mesenchymal stem cells, Randomised controlled trial

2.

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Number of pages: 35 Posted: 28 Jul 2021
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Huazhong University of Science and Technology - Department of Hematology, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China -Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Radiology, Government of the People's Republic of China - Department of Radiology, Wuhan Kingmed Center for Clinical Laboratory Co., Ltd., Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, National Industrial Base for Stem Cell Engineering Products, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 66 (916,100)
Citation 2

Abstract:

Loading...

3.

Safety and Efficacy of Mesenchymal Stem Cells in Severe/Critical COVID-19 Patients: A Systematic Review and Meta-Analysis

Number of pages: 38 Posted: 08 Mar 2022
Wei Qi Yao, Haibo Dong, Ji Qi, Yu Zhang and Lei Shi
Huazhong University of Science and Technology - Department of Hematology, Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd. and Government of the People's Republic of China - Department of Infectious Diseases
Downloads 60 (970,490)

Abstract:

Loading...

Coronavirus disease-19 (COVID-19), Cellular therapy, Mesenchymal stem cells, Systematic review, Meta-analysis.